Literature DB >> 3277130

Gluten-sensitive enteropathy in childhood.

S Auricchio1, L Greco, R Troncone.   

Abstract

Genetic and environmental factors (breast feeding, probably viral infections) play a role in the expression of the disease. Prevalence of GSE in childhood did not substantially decrease in the last 15 years in all European countries, where GSE is still more common in infantile age and presents frequently gastrointestinal symptoms. A decrease has been reported in childhood in several United Kingdom areas and in Finland, where the clinical presentation is changing, shifting upward with age and coming closer to the adult type of the disease. The following clinical problems have been reported in the recent literature: enamel hypoplasia; monosymptomatic short stature; arthritis and other immunologic diseases; association with diabetes, atopy, Iga deficiency, and probably Down's syndrome. Delay in puberty and other peculiar problems of the disease have been described in adolescents. Tests assessing the permeability of the small intestine and the blood levels of antigliadin antibodies have recently gained success as noninvasive tools for the diagnosis of the GSE. The gluten should be withdrawn from the diet and the challenge with gluten should be performed not before 12 months of gluten-free diet with an accurate timing of the biopsy on the basis of the antigliadin and antireticulin antibodies, to avoid clinical and growth damage. Celiac children do require a permanent gluten-free (and not poor) diet. In reality, too many celiac adolescents are off-diet.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3277130     DOI: 10.1016/s0031-3955(16)36405-7

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  13 in total

1.  History of coeliac disease.

Authors:  S Auricchio; R Troncone
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

2.  Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.

Authors:  S Fais; L Maiuri; F Pallone; M De Vincenzi; G De Ritis; R Troncone; S Auricchio
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Unchanging clinical picture of coeliac disease presentation in Campania, Italy.

Authors:  L Greco; A E Tozzi; M Mayer; M Grimaldi; G Silano; S Auricchio
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

4.  Diagnosis of coeliac disease: time for a change?

Authors:  S Guandalini; A Ventura; N Ansaldi; A M Giunta; L Greco; R Lazzari; G Mastella; A Rubino
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

5.  Changing infant feeding practices and declining incidence of coeliac disease in West Somerset.

Authors:  D N Challacombe; I K Mecrow; K Elliott; F J Clarke; E E Wheeler
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

6.  Screening tests for coeliac disease.

Authors:  D N Challacombe
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

7.  Is an intestinal permeability test a valid marker for slight dietary transgressions in adolescents with coeliac disease?

Authors:  P Fernández-Calle; R Codoceo; I Polanco; J Gómez-Cerezo; M Orsi; J M Tenias
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

8.  Salivary IgA antigliadin antibody as a marker for coeliac disease.

Authors:  V Hakeem; R Fifield; H F al-Bayaty; M J Aldred; D M Walker; J Williams; H R Jenkins
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

Review 9.  Down syndrome and coeliac disease: five new cases with a review of the literature.

Authors:  M I Hilhorst; M Brink; E A Wauters; R H Houwen
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

10.  Antigliadin and antiendomysium antibody determination for coeliac disease.

Authors:  A Bürgin-Wolff; H Gaze; F Hadziselimovic; H Huber; M J Lentze; D Nusslé; C Reymond-Berthet
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.